# Citalopram for Sx/Util in Acute Coronary Syndrome Patients

> **NCT01667744** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Henry Ford Health System**

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Citalopram

## Key facts

- **NCT ID:** NCT01667744
- **Lead sponsor:** Henry Ford Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01-01
- **Primary completion:** 2016-02-01
- **Final completion:** 2021-02-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** unfunded
- **Last updated:** 2022-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01667744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01667744, "Citalopram for Sx/Util in Acute Coronary Syndrome Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01667744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*